EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
12 hedge funds and large institutions have $188M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Holders
12
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$67M | |
| 2 | +$60.5M | |
| 3 | +$40.5M | |
| 4 |
Blackstone Inc
New York
|
+$18.4M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$347K |
Top Sellers
| 1 | -$9.89M | |
| 2 | -$8.99M | |
| 3 | -$8.54M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.32M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$4.95M |